{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-068092","form_type":"8-K","ticker":null,"cik":"0000786947","company_name":"ACURA PHARMACEUTICALS, INC","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.969144+00:00","generated_at":"2026-06-01T06:39:35.074492+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Acura Pharmaceuticals CFO Peter Clemens to retire effective Sept 30; Robert Seiser appointed successor","bullets":["Peter Clemens steps down as CFO on July 31, 2024, remains VP through Sept 30 for transition.","Robert A. Seiser, currently VP Treasurer & Corporate Controller since 1998, appointed Sr. VP & CFO effective Aug 1, 2024.","Board approved Clemens's retirement and Seiser's appointment on May 31, 2024.","Clemens will continue as Vice President until end of September to ensure smooth handover."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-068092","json":"https://secwatch.observer/filing/0001104659-24-068092.json","markdown":"https://secwatch.observer/filing/0001104659-24-068092.md","text":"https://secwatch.observer/filing/0001104659-24-068092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/0001104659-24-068092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/tm2416319d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:39:35.074492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7b033d3827","claim":"Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer at ACURA PHARMACEUTICALS, INC.","evidence_excerpt":"Also on May 31, 2024, Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer, effective August 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/0001104659-24-068092-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Sr. Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d9c46cfb8c","claim":"Peter A. Clemens retired as Sr. Vice President and Chief Financial Officer at ACURA PHARMACEUTICALS, INC.","evidence_excerpt":"Although Mr. Clemens will remain an employee of the Company as Vice President until the end of September to ensure a smooth transition, he is stepping down as Chief Financial Officer, effective July 31, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/0001104659-24-068092-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Sr. Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}